NCT04508205View on ClinicalTrials.gov

CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 26, 2018

Primary Completion Date

April 18, 2019

Study Completion Date

April 18, 2019

Conditions
Rosacea
Interventions
DRUG

CGB-400

BID application

Trial Locations (3)

32132

Cage Bio Investigative Site 3, Edgewater

92123

Cage Bio Investigative Site 2, San Diego

94538

Cage Bio Investigative Site 1, Fremont

Sponsors

Lead Sponsor

CAGE Bio Inc.
All Listed Sponsors
collaborator

ethica Clinical Research Inc.

INDUSTRY

lead

CAGE Bio Inc.

INDUSTRY

NCT04508205 - CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes | Biotech Hunter | Biotech Hunter